Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yoon

Showing results (861-870 of 954) with videos related to

Pageof 96
Sort By:
The British Journal of Dermatology|March 18, 2021
Effect of dermatological consultation on survival in patients with checkpoint inhibitor-associated cutaneous toxicityL L Thompson, E B Li, N A Krasnow, et al.
HGG Advances|May 22, 2024
Whole-genome sequences reveal zygotic composition in chimeric twinsChristopher J Yoon, Chang Hyun Nam, Taewoo Kim, et al.
Cancer Letters|May 4, 2024
BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabineAubrey L Miller, Samuel C Fehling, Rebecca B Vance, et al.
Schizophrenia Research|January 27, 2004
Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patientsJ K Park, H J Lee, J W Kim, et al.
Biomaterials|July 17, 2017
Hyperactive FOXO1 results in lack of tip stalk identity and deficient microvascular regeneration during kidney injuryLan T H Dang, Takahide Aburatani, Graham A Marsh, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 20, 2021
Guiding therapeutic plasma exchange for antibody-mediated rejection treatment in lung transplant recipients - a retrospective studyOlga A Timofeeva, Jason Choe, Mohamed Alsammak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 29, 2016
Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibitionS T Kim, S Y Kim, S J Klempner, et al.
Neurogastroenterology and Motility|March 27, 2015
Long-term efficacy of biofeedback therapy in patients with dyssynergic defecation: results of a median 44 months follow-upH J Lee, S-J Boo, K W Jung, et al.
International Journal of Bioprinting|June 16, 2023
Using 3D-bioprinted models to study pediatric neural crest-derived tumorsColin H Quinn, Andee M Beierle, Janet R Julson, et al.
FEBS Letters|July 14, 1998
Molecular cloning of a novel GTP-binding protein induced in fish cells by rhabdovirus infectionE H Lee, H J Kim, J J Park, et al.
Pageof 96

Showing results (861-870 of 954) with videos related to

Sort By:
Pageof 96
The British Journal of Dermatology|March 18, 2021
Effect of dermatological consultation on survival in patients with checkpoint inhibitor-associated cutaneous toxicityL L Thompson, E B Li, N A Krasnow, et al.
HGG Advances|May 22, 2024
Whole-genome sequences reveal zygotic composition in chimeric twinsChristopher J Yoon, Chang Hyun Nam, Taewoo Kim, et al.
Cancer Letters|May 4, 2024
BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabineAubrey L Miller, Samuel C Fehling, Rebecca B Vance, et al.
Schizophrenia Research|January 27, 2004
Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patientsJ K Park, H J Lee, J W Kim, et al.
Biomaterials|July 17, 2017
Hyperactive FOXO1 results in lack of tip stalk identity and deficient microvascular regeneration during kidney injuryLan T H Dang, Takahide Aburatani, Graham A Marsh, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 20, 2021
Guiding therapeutic plasma exchange for antibody-mediated rejection treatment in lung transplant recipients - a retrospective studyOlga A Timofeeva, Jason Choe, Mohamed Alsammak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 29, 2016
Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibitionS T Kim, S Y Kim, S J Klempner, et al.
Neurogastroenterology and Motility|March 27, 2015
Long-term efficacy of biofeedback therapy in patients with dyssynergic defecation: results of a median 44 months follow-upH J Lee, S-J Boo, K W Jung, et al.
International Journal of Bioprinting|June 16, 2023
Using 3D-bioprinted models to study pediatric neural crest-derived tumorsColin H Quinn, Andee M Beierle, Janet R Julson, et al.
FEBS Letters|July 14, 1998
Molecular cloning of a novel GTP-binding protein induced in fish cells by rhabdovirus infectionE H Lee, H J Kim, J J Park, et al.
Pageof 96